Large‐scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease

Itoh, Nobuo, Arai, Hiroyuki, Urakami, Katsuya, Ishiguro, Koichi, Ohno, Hideto, Hampel, Harald, Buerger, Katharina, Wiltfang, Jens, Otto, Markus, Kretzschmar, Hans, Moeller, Hans‐Juergen, Imagawa, Masaki, Kohno, Hideki, Nakashima, Kenji, Kuzuhara, Shigeki, Sasaki, Hidetada, Imahori, Kazutomo·2001·Annals of Neurology

DOI 10.1002/ana.1054

Cited by (254)

Items 101–200 of 254

Biomarkers in biological fluids for dementia with Lewy bodies
Sebastian Schade, Brit Mollenhauer · 2014 · Alzheimer s Research & Therapy
Biomarkers for Alzheimer Disease in Cerebrospinal Fluid, Urine, and Blood
Anders Lönneborg · 2008 · Molecular Diagnosis & Therapy
ApoE Alleles and Tau Markers in Patients with Different Levels of Cognitive Impairment
Manuel Lavados M, Gustavo A. Farias, Francisco Rothhammer, Marta Guillón, María Victoria Mujica, Cristóbal Maccioni, Ricardo Benjamin Maccioni · 2005 · Archives of Medical Research
CSF phosphorylated tau—does it constitute an accurate biological test for Alzheimer's disease?
Alex J. Mitchell, Nick Brindle · 2003 · International Journal of Geriatric Psychiatry
The prevalence and biomarkers’ characteristic of rapidly progressive Alzheimer's disease from the Alzheimer's Disease Neuroimaging Initiative database
Maowen Ba, Xiaofeng Li, Kok Pin Ng, Tharick Ali Pascoal, Sulantha Sanjeewa Mathotaarachchi, Pedro Rosa‐Neto, Serge G. Gauthier, Alzheimer’s Disease Neuroimaging Initiative · 2017 · Alzheimer s & Dementia Translational Research & Clinical Interventions
Autoantibodies targeting neuronal proteins as biomarkers for neurodegenerative diseases
Gabriela Kocurova, Jan Říčný, Saak Victor Ovsepian · 2022 · Theranostics
Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer’s disease and vascular dementia
Sabrina Ravaglia, Paola Bini, Elena Sinforiani, Diego M Franciotta, Elisabetta Zardini, P. Tosca, Arrigo Moglia, Alfredo Cardoso Costa · 2008 · Neurological Sciences
Increased levels of CSF phosphorylated tau in apolipoprotein E ɛ4 carriers with mild cognitive impairment
Katharina Büerger, Stefan Johannes Teipel, Raymond P. Zinkowski, Trey Sunderland, Niels Andreasen, Kaj Blennow, Michael Ewers, John F. DeBernardis, Yong Shen, Daniel J. Kerkman et al. · 2005 · Neuroscience Letters
Neurochemical dementia diagnostics in Alzheimer’s disease: where are we now and where are we going?
Piotr Lewczuk, Johannes Kornhuber · 2011 · Expert Review of Proteomics
Biomarkers of Mild Cognitive Impairment and Alzheimer’s Disease
Bor Luen Tang, Rajeev Kumar · 2008 · Annals of the Academy of Medicine Singapore
Posterior cortical atrophy with [11C] Pittsburgh compound B accumulation in the primary visual cortex
Taiki Kambe, Yumiko Motoi, Kenji Ishii, Nobutaka Hattori · 2009 · Journal of Neurology
Alzheimer's disease biomarkers: correspondence between human studies and animal models
Sabbagh, Jonathan J., Kinney, Jefferson W., Cummings, Jeffrey L. · 2013 · Neurobiology of Disease
Post-Translational Modifications in Alzheimer's Disease and the Potential for New Biomarkers
Claire L. Russell, Saša Končarević, Malcolm Andrew Ward · 2014 · Journal of Alzheimer s Disease
Role of Body-Fluid Biomarkers in Alzheimer’s Disease Diagnosis
Thuy Trang Nguyen, Qui Thanh Hoai Ta, Thi Kim Oanh Nguyen, Thi Kim Oanh Nguyen, Vo Van Giau · 2020 · Diagnostics
CSF-studies in neuropsychiatric disorders.
Thomas J. Raedler, Klaus Wiedemann · 2006 · PubMed
Plasma Homocysteine and Risk of Coexisting Silent Brain Infarction in Alzheimer’s Disease
Toshifumi Matsui, Miyako Nemoto, Masahiro Maruyama, Takefumi Yuzuriha, Hiroshi Yao, Haruko Tanji, Mari Ootsuki, Naoki Tomita, Sachio Matsushita, Susumu Higuchi et al. · 2005 · Neurodegenerative Diseases
Cerebrospinal fluid and blood biomarkers in the diagnostic assays of Alzheimer’s disease
Liding Zhang, Xiaohan Liang, Zhihong Zhang, Haiming Luo · 2021 · Journal of Innovative Optical Health Sciences
Cerebrospinal fluid biomarkers of Alzheimer’s disease in cognitively healthy elderly
Lidia Glodzik · 2013 · Frontiers in bioscience
Role of Biochemical Alzheimer's Disease Biomarkers as End Points in Clinical Trials
Eric Siemers, Ronald Bradley Demattos, Patrick C. May, Robert A. Dean · 2010 · Biomarkers in Medicine
Measurement of ERK 1/2 in CSF from Patients with Neuropsychiatric Disorders and Evidence for the Presence of the Activated Form
H. Klafki, P. Lewczuk, H. Kamrowski-Kruck, J. Maler, Katharina Müller, O. Peters, I. Heuser, F. Jessen, J. Popp, L. Frölich et al. · 2009 · Journal of Alzheimer's Disease
RNA Interference Silencing of Glycogen Synthase Kinase 3β Inhibites Tau Phosphorylation in Mice with Alzheimer Disease
Hong Bian, Wei Bian, Xiaoying Lin, Zhaoyin Ma, Wen Chen, Ying Dong Pu · 2016 · Neurochemical Research
Early detection and personalized medicine: Future strategies against Alzheimer's disease
Antonio Di Meco, Robert J. Vassar · 2020 · Progress in molecular biology and translational science
Current Progress and Future Directions for Tau-Based Fluid Biomarker Diagnostics in Alzheimer’s Disease
Mohammad Arastoo, Richard A. Lofthouse, Lewis K. Penny, Charles R. Harrington, Andy Porter, Claude M. Wischik, Soumya Palliyil · 2020 · International Journal of Molecular Sciences
Tau phosphorylation pathway genes and cerebrospinal fluid tau levels in Alzheimer's disease
Lynn M. Bekris, Steve Millard, Franziska Lutz, Gail Li, Doug R. Galasko, Martin Rhys Farlow, Joseph F. Quinn, Jeffrey Alan Kaye, James B. Leverenz, Debby W. Tsuang et al. · 2012 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
Site‐specific phosphorylation of Tau protein is associated with deacetylation of microtubules in mouse spermatogenic cells during meiosis
Hiroki Inoue, Yuuki Hiradate, Yoshiki Shirakata, Kenta Kanai, Keita Kosaka, Aina Gotoh, Yasuhiro Fukuda, Yutaka Nakai, Takafumi Uchida, Eimei Sato et al. · 2014 · FEBS Letters
Neurochemical biomarkers in Alzheimer’s disease and related disorders
Mirko Bibl, Hermann Esselmann, Jens Wiltfang · 2012 · Therapeutic Advances in Neurological Disorders
The use of non-prion biomarkers for the diagnosis of Transmissible Spongiform Encephalopathies in the live animal
Ifat Parveen, Jon M. Moorby, Gordon G Allison, Roy Jackman · 2005 · Veterinary Research
Clinical and biomarker investigation of a patient with a novel presenilin-1 mutation (A431V) in the mild cognitive impairment stage of Alzheimer’s Disease
Sachio Matsushita, Hiroyuki Arai, Nobuyuki Okamura, Tomohiro Ohmori, Keiichi Takasugi, Toshifumi Matsui, Masahiro Maruyama, Takeshi Iwatsubo, Susumu Higuchi · 2002 · Biological Psychiatry
Differential diagnosis of neurodegenerative diseases with special emphasis on Creutzfeldt-Jakob disease
Markus Otto, Jens Wiltfang · 2003 · Restorative Neurology and Neuroscience
Cerebrospinal Fluid and Plasma Tau as a Biomarker for Brain Tauopathy
Mikio Shoji · 2019 · Advances in experimental medicine and biology
Cerebrospinal fluid levels of phosphorylated tau and Aβ1-38/Aβ1-40/Aβ1-42 in Alzheimer’s disease with PS1 mutations
Masaki Ikeda, Kimie Yonemura, Satoko Kakuda, Yuichi Tashiro, Yukio Fujita, Eriko Takai, Yukiko Hashimoto, Kouki Makioka, Natsumi Furuta, Koichi Ishiguro et al. · 2013 · Amyloid
Biological markers of Alzheimer's disease
Pankaj D Mehta, Tuula Pirttilä · 2002 · Drug Development Research
Novel Biomarkers for Alzheimer’s Disease: Plasma Neurofilament Light and Cerebrospinal Fluid
Daniel Naawenkangua Abukuri · 2024 · International Journal of Alzheimer s Disease
Ovine serum biomarkers of early and late phase scrapie
Isabelle Batxelli-Molina, Nicolas Salvetat, Olivier Andréoletti, Luc Guerrier, Guillaume Vicat, Franck Molina, Chantal Mourton-Gilles · 2010 · BMC Veterinary Research
Cerebrospinal fluid biomarkers of Alzheimer’s disease
Xiaojing Sui, Jianjun Liu, Xifei Yang · 2014 · Neuroscience Bulletin
Current Strategies in The Discovery of Small-Molecule Biomarkers for Alzheimer’s Disease
Luke Whiley, Cristina Legido‐Quigley · 2011 · Bioanalysis
Illustrated Neuropathologic Diagnosis of Alzheimer’s Disease
Nicholas Doher, Vahid Davoudi, Shino Magaki, Ryan A. Townley, Mohammad Haeri, Harry V. Vinters · 2023 · Neurology International
CSF biomarkers in frontotemporal lobar degeneration: relations with clinical characteristics, apolipoprotein E genotype, and neuroimaging
Yolande A.L. Pijnenburg · 2006 · Journal of Neurology Neurosurgery & Psychiatry
Alzheimer's disease
Alberto Serrano‐Pozo, Valentina Escott‐Price, Lea T. Grinberg, Tharick Ali Pascoal, Marc Suárez‐Calvet, Bruno Dubois, Reisa Anne Sperling · 2026 · The Lancet
Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer’s disease
Karl Hansson, Rahil Dahlén, Oskar Hansson, Elin Pernevik, Ross W. Paterson, Jonathan M. Schott, Nadia K. Magdalinou, Henrik Zetterberg, Kaj Blennow, Johan Gobom · 2019 · Clinical mass spectrometry
A clinical and neuropathological study of an unusual case of sporadic tauopathy. A variant of corticobasal degeneration?
Shinji Ohara, Jun Tsuyuzaki, Takashi Oide, Hiroyuki Arai, Susumu Higuchi, Masato Hasegawa, Takeshi Iwatsubo · 2002 · Neuroscience Letters
Medical Treatments and Cares for Geriatric Syndrome: New Strategies Learned from Frail Elderly
Hiroshi Kubo, Katsutoshi Nakayama, Satoru Ebihara, Hidetada Sasaki · 2005 · The Tohoku Journal of Experimental Medicine
How proteomics reveals potential biomarkers in brain diseases
Oliver Schmidt, Thomas Schulenborg, Helmut E. Meyer, Katrin Marcus, Michael Hamacher · 2005 · Expert Review of Proteomics
Biomarkers of the Dementia
Mikio Shoji · 2011 · International Journal of Alzheimer s Disease
Paradigm shift redefining molecular, metabolic and structural events in Alzheimer’s disease involves a proposed contribution by transition metals. Defined lengthy preclinical stage provides new hope to circumvent advancement of disease- and age-related neurodegeneration
Franco Cavaleri · 2015 · Medical Hypotheses
Cerebrospinal fluid tau and Aβ42 concentrations in healthy subjects: delineation of reference intervals and their limitations
Pierre R. Burkhard, Roxane Fournier, Bernadette Mermillod, Karl‐Heinz Krause, Constantin Bouras, Irmgard Irminger‐Finger · 2004 · Clinical Chemistry and Laboratory Medicine (CCLM)
Article Commentary: Alzheimer's Disease, Diagnosis and the Need for Biomarkers
Claudie Hooper, Simon Lovestone, Ricardo Sáinz‐Fuertes · 2008 · Biomarker Insights
Cerebrospinal Fluid Biomarkers in Alzheimer Disease
Douglas R Galasko · 2003 · Archives of Neurology
Tracking the potential involvement of metabolic disease in Alzheimer's disease—Biomarkers and beyond
Jose Alejandro Luchsinger, Henrik Zetterberg · 2020 · International review of neurobiology
Detection of misfolded protein aggregates from a clinical perspective
Øyvind Strømland, Martin Jakubec, Samuel Furse, Øyvind Halskau · 2016 · Journal of Clinical and Translational Research
Biochemical markers of Alzheimer’s disease: wish and reality
Andreas Papassotiropoulos, Christoph Höck · 2002 · Neurobiology of Aging
Molecular Approaches to the Treatment, Prophylaxis, and Diagnosis of Alzheimer’s Disease: Clinical Molecular and Genetic Studies on Alzheimer’s Disease
Mikio Shoji · 2012 · Journal of Pharmacological Sciences
Neurofilaments and progranulin are related to atrophy in frontotemporal lobar degeneration – A transdiagnostic study cross‐validating atrophy and fluid biomarkers
Lea Hüper, Petra Steinacker, Maryna Polyakova, Karsten Mueller, Jannis Godulla, Sabine Herzig, Adrian Danek, Annerose Engel, Janine Diehl‐Schmid, Joseph Claßen et al. · 2024 · Alzheimer s & Dementia
Biomarkers Differentiating Dementia with Lewy Bodies from Other Dementias: A Meta-Analysis
Aki Mishima, Takashi Nihashi, Yoshio Ando, Hisashi Kawai, Takashi Kato, Kengo Ito, Teruhiko Terasawa · 2016 · Journal of Alzheimer s Disease
Structural Magnetic Resonance Imaging Markers of Alzheimer’s Disease and Its Retranslation to Rodent Models
Zsigmond Tamás Kincses, András Király, Dániel Veréb, László Vécsei · 2015 · Journal of Alzheimer s Disease
Evaluation of a computerized test system to screen for mild cognitive impairment
Masashi Inoue, Katsuya Urakami, Miyako Taniguchi, Yuki Kimura, Jun SAITO, Kenji Nakashima · 2005 · Psychogeriatrics
Prognostischer und differenzialdiagnostischer Stellenwert der Liquordiagnostik bei neurodegenerativen Demenzerkrankungen
Robert Haußmann, P. Homeyer, M. D. Brandt, Markus Donix · 2022 · Der Nervenarzt
The epidemiology of dementia in Taiwan.
Ching‐Kuan Liu · 2006 · PubMed
CSF tau and amyloid β42 levels in Alzheimer’s disease—A meta-analysis
Rachna Agarwal, Neelam Chhillar, Vijaya Nath Mishra, Chandra Bhushan Tripathi · 2012 · Advances in Alzheimer s Disease
Laboratory biomarkers in Alzheimer’s disease
Joshua R. Steinerman, Lawrence S. Honig · 2007 · Current Neurology and Neuroscience Reports
Tau Protein as a Biological Fluid Biomarker in Neurodegenerative Dementias
Franc Llorens, Anna Villar‐Piqué, Niccolò Candelise, Isidró Ferrer, Inga Zerr · 2019 · IntechOpen eBooks
EDITORIAL: Diagnostic biomarker for early stage of Alzheimer's disease: Current state and view in the future
Katsuya Urakami · 2010 · Psychogeriatrics
Neuroprevention: A new challenge?
Jean‐Christophe Corvol · 2012 · Revue Neurologique
CSF tau proteins in differential diagnosis of dementia
Marina Boban, Helena Šarac, Ninoslav Mimica, Mihovil Mladinov, Christine Süßmair, Nibal Ackl, Benedikt Bader, Miljenko Huzak, Adrian Danek, Patrick R. Hof et al. · 2010 · Translational Neuroscience
Cerebrospinal Fluid τ Protein in Differential Diagnosis of Alzheimer’s Disease and Vascular Dementia in Chinese population
Bo Liu, Yulan Tang, Yuefei Shen, Luan Cen, Han Min · 2013 · American Journal of Alzheimer s Disease & Other Dementias®
Investigating the Potential Impact of Air Pollution on Alzheimer’s Disease and the Utility of Multidimensional Imaging for Early Detection
Ankul Singh S, Mohd Nazam Ansari, Gehan M. Elossaily, Chitra Vellapandian, Bhupendra Gopalbhai Prajapati · 2024 · ACS Omega
Investigating the Impact of Sorghum on Tau Protein Phosphorylation and Mitochondrial Dysfunction Modulation in Alzheimer’s Disease: An In Vitro Study
Nasim Rezaee, Eugene Hone, Hamid Reza Sohrabi, Abdulraheem R. Adisa, Stuart Keith Johnson, Stuart T. Gunzburg, Ralph Nigel Martins, Warnakulasuriya Mary Ann Dipika Binosha Fernando · 2025 · Nutrients
Development of a simplified Short-Term Memory recall Test (STMT) and its clinical evaluation
Naoto Kobayashi, Kyoko Nakano, Hisao Tago, Shin‐Ichi Niwa · 2010 · Aging Clinical and Experimental Research
The Erlangen Score Algorithm in the diagnosis and prediction of the progression from subjective cognitive decline and mild cognitive impairment to Alzheimer-type dementia
Anna Filipek-Gliszczyńska, Anna K. Barczak, Magdalena Budziszewska, Monika Mandecka, Tomasz Gabryelewicz, Maria Barcikowska · 2018 · Folia Neuropathologica
Job Related Burnout among Emergency Physicians and Nurses in Dammam City, Saudi Arabia
AbdulazizF. Alshahrani, Abdullah M. Alhotheyfa, Salman Z. Alkhiraisy, Hassan Abugad, Bander F. Alshahrani · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
Stress and a sedentary lifestyle are associated with irritable bowel syndrome in medical students from Saudi Arabia
Bashir Fadl AF, Asrar Mohammed Al-Towerqi, Arwa Alharbi, Danah kamal kabrah, Amwaj Abdulmohsen Almalki, Bashayer Nawar Algethami, Afaf F Albogami · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
Biomarker identification for diagnosis of Alzheimer's disease
Steven Pelech · 2008 · Expert Opinion on Medical Diagnostics
"Phosphorylation of The Tau Protein in Neurodegenerative Disease"
Keping Chen · 2020 · Biomedical Journal of Scientific & Technical Research
HMGB1 Box A gene therapy reverses cognitive and neuropathological features in AlCl₃/D-galactose rat model of Alzheimer's disease
Suangsuda Supasai, Pakawat Suntaratti, Mingkwan Odton, Tasneem Longji, Thararat Karananan, Sakawdaurn Yasom, Sumate Ampawong, Yanin Limpanont, Apiwat Mutirangura · 2025 · Experimental Neurology
Exploring the Treatment Types and Challenges in Patients with Chronic Obstructive Pulmonary Disease: A Qualitative Study
Mian Ali Kamran Baba, Shaheer Ellahi Khan, Fatima Hasnain, Rabab Sakina, Afsheen Talat, Afifa Binte Irfan · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
Biomarkers in non-Alzheimer dementias
Douglas R Galasko · 2004 · Clinical Neuroscience Research
Neurochemical Dementia Diagnostics for Alzheimer‘s Disease and Other Dementias: An ISO 15189 Perspective
Johanna Waedt, Martina Kleinow, Johannes Kornhuber, Piotr Lewczuk · 2012 · Biomarkers in Medicine
Vers un diagnostic biologique de la maladie d’Alzheimer et des syndromes apparentés
Pierre Krolak‐Salmon, Jérémie Seguin, Armand Perret‐Liaudet, Virginie Desestret, Alain Vighetto, Marc Bonnefoy · 2008 · La Revue de Médecine Interne
Public Awareness, and Perception towards Chronic Kidney Disease and its Risk Factors in Southern Region, Saudi Arabia
Mona Mohammed Alshahrani, Haifa’ Hisham A. Alwabel, Hassan Dhafer Alabisi, Mohammed Abdullah Alshehr, Abdulaziz M. Alqahtani, Anas Ali Asiri, Manar Alqahtani · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
Alzheimerdemenz: Positivdiagnostik und Prävention
Johannes Kornhuber · 2002 · Der Nervenarzt
Fluid biomarkers in the evolving care landscape of Alzheimer's disease and related disorders
Charlotte Elisabeth Teunissen, Lisa Vermunt, Nicholas R Barthélemy, Tammie L.S. Benzinger, Jonathan Graff‐Radford, Inge M.W. Verberk, Henrik Zetterberg, Suzanne E. Schindler, Clifford R. Jack · 2026 · The Lancet Neurology
Candidate Bio-Markers of Alzheimer’s Disease
Balachandran Krishnamma Binukumar, Chandrashekaran Harish · 2013 · InTech eBooks
Currently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment
Piotr Lewczuk · 2014 · Advances in Geriatrics
Aktuelle klinisch-neurochemische Diagnostik der Alzheimer-Krankheit/Current Clinical Neurochemical Diagnosis of Alzheimer’s Disease
N. Rösler, Ildiko Wichart, K. A. Jellinger · 2002 · Journal of Laboratory Medicine
Why patients go to private health care facilities? Perspectives from Qassim, Saudi Arabia
Amel Abdalrhim Sulaiman, Unaib Rabbani, Sultan S. AlShaya, Marwan Alyahya, Saleh A Al-Gabbany, Chandra Sekhar Kalevaru, Saulat Jahan, Raed A Aljubeilan, Ahmed Almeman, Bader A AlAhajji · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
Biomarkers for Alzheimer's Disease – An Overview
Uma Tyagi, Divya Bajpai Tripathy, Anjali Gupta, Kiran Bisht, Anurag Nain · 2024 · Macromolecular Symposia
The Effect of Acetylcholine Esterase Inhibitor on Cerebrospinal Fluid $\beta$-Amyloid 1-42 and Phosphorylated Tau Protein in Korean Alzheimer’s Disease Patients: Preliminary Study
Eun Hui Lee, Young Chul Youn, Kwang‐Yeol Park, Ju Hong Min, Oh Sang Kwon, Hyun Ok Lee, Hyun Jong Hong · 2008 · Journal of the Korean Neurological Association
miRNAs as biofluid markers for diagnostics of Alzheimer’s disease: recent status and perspectives
Nina Kosikova, Martin Cente, Viera Cigánková, Peter Koson, Peter Filipčík · 2018 · General Physiology and Biophysics
Demenz
Jens Wiltfang, Sarah Trost, Harald-Jürgen Hampel · 2017 · Springer eBooks
Vascular factors in Alzheimer's disease
Katsuya Urakami · 2004 · Psychogeriatrics
Awareness and Knowledge about Childhood Autism among Family Medicine Residents in Al Madinah Region in Saudi Arabia, 2020
Ahmad M Masarit, Maher Alhafithi, Haytham Alsanna, Sokinh Almaghaslah · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
Nutrition and puberty
Dima Naddeh, Alaa Salah AG Alsharei · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
Prevalence and associated factors of burnout among nurses in a general hospital in Yanbu, Saudi Arabia
Maher Alhafithi, Sami Abdo Radman Al‐Dubai, Saleh S Alalwan, Ahmad M Masarit · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
Trabalho de consenso de força-tarefa da WFSBP sobre marcadores biológicos das demências: contribuição da análise do LCR e do sangue para o diagnóstico precoce e diferencial das demências
Jens Wiltfang, Piotr Lewczuk, Peter Riederer, Edna Grünblatt, C Hock, Philip Scheltens, Harald Juergen Hampel, Hugo Vanderstichele, Kamaschufi Iqbal, Doug R. Galasko et al. · 2009 · Archives of Clinical Psychiatry (São Paulo)
Alzheimer’s Diseases: Towards Biomarkers for an Early Diagnosis
Benaïssa Elmoualij, Ingrid Dupiereux-Fettweis, Jérémie Seguin, Isabelle Quadrio, Willy Zorzi, Armand Perret‐Liaudet, Ernst Heine · 2011 · InTech eBooks
Biomarkers of Alzheimer’s disease
Jason E. Pitt · 2014 · Elsevier eBooks
Cerebrospinal fluid biomarkers for neurodegenerative disorders
Rita Margarida Almeida Santos Videira · 2013 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Physicians’ Perceptions and Attitudes toward Use of Electronic Medical Record Systems in Riyadh
Yasser H. AlOtaib, Moteb AlSaedi · 2022 · World Family Medicine Journal/Middle East Journal of Family Medicine
A case report of late-onset schizophrenia differentiated from a dementing disorder
Takamitsu Shimada, Takashi Uehara, Tatsuya Nagasawa, Mitsuru Hasegawa, Yoshiki Maeda, Yasuhiro Kawasaki · 2021 · Neurocase
Advances On Biological Markers In Early Diagnosis Of Alzheimer Disease
Alessandro Padovani, Barbara Borroni, Mónica Di Luca · 2005 · Advances in clinical chemistry